Print Friendly, PDF & Email

NCT/Study#

NCT04943900 /

CA102-003

Phase 1 Study Of BMS-986416 (TGF-B Inhibitor) Alone And In Combination With Nivolumab In Advanced Malignant Tumors.

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: